GOJOYNER Trademark
GOJOYNER is a USPTO trademark filed by Bristol-Myers Squibb Company. Status: Pending.
Prosecution Summary
Trademark Summary
GOJOYNER is a standard character mark covering pharmaceutical preparations in International Class 005 for treating obesity, cardiovascular diseases, cancer, inflammatory diseases, and other specified conditions, including antivirals, antibodies, biological preparations, anticoagulants, stem cells, and diagnostic radiopharmaceuticals; it also spans Domestic Classes 006, 018, 044, 046, 051, and 052. The application is on the Principal Register under intent-to-use basis and has reached Notice of Allowance issued status as of December 2, 2025, requiring a Statement of Use or extension within six months. Owner is Bristol-Myers Squibb Company, a Delaware corporation based in Princeton, New Jersey. No notable issues or legal proceedings are present.
**Recent A
Trademark Facts
| Mark | GOJOYNER |
|---|---|
| Serial Number | 99126610 |
| Status | Pending |
| Filing Date | 2025-04-08 |
| Mark Type | Word |
| Nice Classes | 005 (Pharmaceuticals) |
| Owner | Bristol-Myers Squibb Company |
| Attorney of Record | Marilyn F. Kelly |
| Prosecution Events | 9 |
| Latest Event | NOAM on 2025-12-02 |
Goods & Services
Pharmaceutical preparations for the treatment and prevention of obesity, cardiovascular diseases, central nervous system diseases, metabolic disorders, stroke, cancer, inflammatory diseases, respiratory diseases, infectious diseases, auto-immune diseases, solid organ transplant rejection, autoinflammatory disease, blood disease, multiple sclerosis, ulcerative colitis, cystic fibrosis, arthritis, and musculoskeletal and skin disease; Antivirals; Antibodies for medical purposes; Biological preparations for the treatment of cancer; Anticoagulants; Stem cells for medical purposes; Radiopharmaceutical preparations for the treatment of cancer and solid tumors; Diagnostic radiopharmaceutical preparations; Diagnostic preparations for medical purposes